Skip to main content
. 2017 Mar 16;8(16):27454–27470. doi: 10.18632/oncotarget.16247

Figure 4. The effect of EGFR on cell motility is related to Co-029 expression.

Figure 4

(A) Increased motility of Is1-Co029 cells induced by chemical inhibitor of EGFR, AG1478, (B) by silencing of EGFR, and reversion by Co-029 silencing or addition of the Co-029 mAb Ts29.1 (for si-CTRL = siCD53). (C) Increased motility induced by Cetuximab and reversion by addition of the Co-029 mAb Ts29.1. (D) Inhibition of Is1-Co029 cell motility by integrins VLA1 and VLA2 RNAi. Asterisks indicates p≤.0001.